Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000621978 | SCV000737257 | uncertain significance | Cardiovascular phenotype | 2017-05-09 | criteria provided, single submitter | clinical testing | The p.N5685S variant (also known as c.17054A>G), located in coding exon 66 of the TTN gene, results from an A to G substitution at nucleotide position 17054. The asparagine at codon 5685 is replaced by serine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Clinical Genetics, |
RCV001700260 | SCV001919007 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV001700260 | SCV001963325 | uncertain significance | not provided | no assertion criteria provided | clinical testing |